WuXi PharmaTech Reaches New 12-Month High at $29.13 (WX)
WuXi PharmaTech (NYSE:WX)’s share price reached a new 52-week high during trading hours on Friday, Stock Ratings Network reports. The company traded as high as $29.13 and last traded at $28.81, with a volume of 459,049 shares traded. The stock had previously closed at $28.15.
Several analysts have recently commented on the stock. Analysts at Janney Montgomery Scott initiated coverage on shares of WuXi PharmaTech (NYSE:WX) in a research note to investors on Thursday, August 15th. They set a “neutral” rating on the stock. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of WuXi PharmaTech (NYSE:WX) in a research note to investors on Tuesday, August 13th. They now have a $28.00 price target on the stock, up previously from $24.00. Finally, analysts at Oppenheimer raised their price target on shares of WuXi PharmaTech (NYSE:WX) from $25.00 to $28.00 in a research note to investors on Tuesday, August 13th. They now have an “outperform” rating on the stock. Three equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. WuXi PharmaTech has a consensus rating of “Buy” and a consensus price target of $22.66.
WuXi PharmaTech has a one year low of $13.54 and a one year high of $29.01. The stock’s 50-day moving average is $25.9 and its 200-day moving average is $21.45. The company has a market cap of $2.051 billion and a P/E ratio of 20.68.
WuXi PharmaTech (NYSE:WX) last released its earnings data on Monday, August 12th. The company reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.07. The company had revenue of $142.33 million for the quarter, compared to the consensus estimate of $141.10 million. During the same quarter last year, the company posted $0.33 earnings per share. WuXi PharmaTech’s revenue was up 9.2% compared to the same quarter last year. Analysts expect that WuXi PharmaTech will post $1.62 EPS for the current fiscal year.
WuXi PharmaTech (NYSE:WX) Inc, (WuXi) is a pharmaceutical, biotechnology and medical device research and development (R&D) outsourcing company, with operations in People’s Republic of China and the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.